Our approach
Open menu
Our Approach
Nonclinical Research
Publications
Our Pipeline
Open menu
Our Pipeline
The PI3K – mTOR Pathway
Gedatolisib
Expanded Access Program
About
Open menu
About
Our Team
Board of Directors
Scientific Advisory Board
Investors
Open menu
Investors
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Quote
Stock Chart
Analyst Coverage
IR Alerts
X
Unraveling complexity. Harnessing insights.
NEWS
CONTACT
X
Our approach
Open menu
Our Approach
Nonclinical Research
Publications
Our Pipeline
Open menu
Our Pipeline
The PI3K – mTOR Pathway
Gedatolisib
Expanded Access Program
About
Open menu
About
Our Team
Board of Directors
Scientific Advisory Board
Investors
Open menu
Investors
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Quote
Stock Chart
Analyst Coverage
IR Alerts
X
Corporate Menu
Open menu
Our Approach
Our Approach
Nonclinical Research
Publications
Our Pipeline
Our Pipeline
The PI3K – mTOR Pathway
Gedatolisib
Expanded Access Program
About
About
Board of Directors
Scientific Advisory Board
Our Team
News
Contact
IR Menu
Open menu
Investors
Press Releases
Events & Presentations
Corporate Governance
Committees & Documents
Board of Directors
Scientific Advisory Board
Our Team
SEC Filings
Stock Quote
Stock Chart
Analyst Coverage
IR Alerts
X
Analyst Coverage
Investor Home
Press Releases
Events & Presentations
Corporate Governance
Open menu
Committees & Documents
Board of Directors
Scientific Advisory Board
Our Team
SEC Filings
Stock Quote
Stock Chart
Analyst Coverage
IR Alerts
Firm
Analyst
Cowen and Company, LLC
Boris Peaker, Ph.D., CFA
Craig-Hallum Capital Group LLC
Alexander Nowak, CFA
Jefferies LLC
Maury Raycroft, Ph.D.
Needham and Company, LLC
Gil Blum, Ph.D.